A review from patents inspired by the genus Cannabis
暂无分享,去创建一个
[1] Chas. L. Ashley. The Treatment of Cough , 1906, Medicina, cirurgia, farmacia.
[2] 徐诚. Hemp/silkworm (kiginu) silk high-count blended knitted fabric and manufacturing method thereof , 2010 .
[3] D. Marasco,et al. Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders. , 2016, Recent patents on CNS drug discovery.
[4] S. Montserrat-de la Paz,et al. Hemp ( Cannabis sativa L.) seed oil: analytical and phytochemical characterization of the unsaponifiable fraction. , 2014, Journal of agricultural and food chemistry.
[5] J. Callaway. Hempseed as a nutritional resource: An overview , 2004, Euphytica.
[6] R. Tiwari,et al. Drug delivery systems: An updated review , 2012, International journal of pharmaceutical investigation.
[7] 리터 도리스,et al. Compounds which modulate the cb2 receptor , 2007 .
[8] David T. Brown. Cannabis: The Genus Cannabis , 1998 .
[9] 가르존아아론,et al. Agonists specific for the peripheral cannabinoid receptor , 2000 .
[10] E. Small. A Numerical and Nomenclatural Analysis of Morpho-Geographic Taxa of Humulus , 1978 .
[11] W. Davies. The chemistry of milk , 1936 .
[12] Gianpietro Venturi,et al. Hemp as a raw material for industrial applications , 2004, Euphytica.
[13] M. Cascio,et al. Biosynthesis and Fate of Endocannabinoids. , 2015, Handbook of experimental pharmacology.
[14] P. Dewick,et al. Medicinal Natural Products: A Biosynthetic Approach , 1997 .
[15] A. Gomtsyan,et al. TRPV1 ligands with hyperthermic, hypothermic and no temperature effects in rats , 2015, Temperature.
[16] D. Deutsch,et al. Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia , 2014, PloS one.
[17] ORAL DETECTION TEST FOR CANNABINOID USE , 2017 .
[18] 고토 미카,et al. Cannabinoid receptor modulator , 2004 .
[19] Махамауд А. Элсоли,et al. Method for preparing delta-9-tetrahydrocannabinol esters , 1999 .
[20] R. Verpoorte,et al. Methods for the analysis of cannabinoids in biological materials: a review. , 2004, Phytochemical analysis : PCA.
[21] 赵华伟,et al. Preparation method and application of China hemp fiber , 2013 .
[22] R. Pertwee. Endocannabinoids and Their Pharmacological Actions. , 2015, Handbook of experimental pharmacology.
[23] P. Murumkar,et al. A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents , 2015, Expert opinion on therapeutic patents.
[24] Jan Ludlow. METHOD OF PREPARING DELTA-9- TETRAHYDROCANNABINOL BACKGROUND OF THE INVENTION , 2017 .
[25] J. Breitenbucher. Inhibitors of fatty acid amide hydrolase (FAAH): SAR and results in pre-clinical pain models , 2013 .
[26] 뮬러아담. Process for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts , 2001 .
[27] RECEPTOR RELATED DISEASES WITH CANNABINOID RECEPTOR LIGANDS , 2017 .
[28] S. Wills. CANNABIS USE AND ABUSE BY MAN: AN HISTORICAL PERSPECTIVE , 1998 .
[29] 康红梅,et al. Improved variety breeding technology for industrial cannabis sativa L. , 2013 .
[30] S. Dey,et al. Endocannabinoid signaling at the periphery: 50 years after THC. , 2015, Trends in pharmacological sciences.
[31] D. Deutsch,et al. Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)* , 2015, The Journal of Biological Chemistry.
[32] Мартин Питер Кроппер,et al. Antiperspirant or deodorant compositions , 2005 .
[33] M. Zenk,et al. Prenylation of olivetolate by a hemp transferase yields cannabigerolic acid, the precursor of tetrahydrocannabinol , 1998, FEBS letters.
[34] M. Wink. Medicinal Natural Products. A Biosynthetic Approach , 2002 .
[35] 赵华伟. Hemp stem viscose fiber sanitary towel and preparation method thereof , 2012 .
[36] P. Cullis,et al. Drug Delivery Systems: Entering the Mainstream , 2004, Science.
[37] Emilio Rodríguez-Cerezo,et al. Analysing patent landscapes in plant biotechnology and new plant breeding techniques , 2012, Transgenic Research.
[38] Bethesda,et al. Cannabinoids as antioxidants and neuroprotectants , 2011 .
[39] P. Robson,et al. The Medicinal Uses of Cannabis and Cannabinoids , 2008 .
[40] P. Thanos,et al. Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms , 2015, Molecular pain.
[41] Kathleen L. Hefferon,et al. Nutritionally Enhanced Food Crops; Progress and Perspectives , 2015, International journal of molecular sciences.
[42] E. Small. Evolution and Classification of Cannabis sativa (Marijuana, Hemp) in Relation to Human Utilization , 2015, The Botanical Review.
[43] K. Müller-Vahl,et al. The therapeutic potential of cannabis and cannabinoids. , 2012, Deutsches Arzteblatt international.
[44] A. Zuardi. History of cannabis as a medicine: a review. , 2006, Revista brasileira de psiquiatria.
[45] ダート,マイケル・ジエイ,et al. Compounds that are cannabinoid receptor ligands , 2010 .
[46] M. L. Gerra,et al. Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists. , 2010, Recent patents on CNS drug discovery.
[47] 李惠森. Ultrasonic assisted supercritical CO2 hemp seed oil extraction method , 2012 .
[48] 刘瑞宁. Enzyme oxidation pre-processing technology for hemp fabric , 2010 .
[49] K. Hefferon. Plant biotechnology patents: applications in agriculture and medicine. , 2010, Recent patents on biotechnology.
[50] S. Morimoto,et al. Purification and characterization of cannabichromenic acid synthase from Cannabis sativa. , 1998, Phytochemistry.
[51] H. Lou,et al. Characterization of Lignanamides from Hemp (Cannabis sativa L.) Seed and Their Antioxidant and Acetylcholinesterase Inhibitory Activities. , 2015, Journal of agricultural and food chemistry.
[52] R. Witkamp. The Endocannabinoid System: A Dynamic Signalling System at the Crossroads Between Metabolism and Disease , 2014 .
[53] C. Andre,et al. Cannabis sativa: The Plant of the Thousand and One Molecules , 2016, Front. Plant Sci..
[54] R. Verpoorte,et al. Secondary metabolism in cannabis , 2008, Phytochemistry Reviews.
[55] 威廉·W·托德. Cannabis drug delivery and monitoring system , 2011 .
[56] M. Maccarrone,et al. The endocannabinoid system: an overview , 2011, Front. Behav. Neurosci..
[57] C. Brenner. Intellectual Property Rights and Technology Transfer in Developing Country Agriculture: Rhetoric and Reality , 1998 .
[58] 刘国忠,et al. Manufacturing method of bast fiber nonwoven fabric , 2008 .
[59] A. Persidis. Agricultural biotechnology , 1991, Nature Biotechnology.
[60] M. Mor,et al. Fatty acid amide hydrolase inhibitors: a patent review (2009 – 2014) , 2015, Expert opinion on therapeutic patents.
[61] R. Cook-Deegan,et al. After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents , 2014, Current Genetic Medicine Reports.
[62] 휘틀 브라이언앤쏘니. Cannabinoid liquid formulations for mucosal administration , 2003 .
[63] 季国苗. China hemp and cotton mixed fiber fabric , 2010 .
[64] S. Gaetani,et al. Modulation of anxiety through blockade of anandamide hydrolysis , 2003, Nature Medicine.
[65] E. Heerdink,et al. The prevalence and incidence of medicinal cannabis on prescription in The Netherlands , 2013, European Journal of Clinical Pharmacology.
[66] S. Davis,et al. Endocannabinoid system overactivity and the metabolic syndrome: Prospects for treatment , 2008, Current diabetes reports.
[67] B. Hawes,et al. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells , 2008, British journal of pharmacology.
[68] 张建春,et al. Hemp knitting face fabric , 2009 .
[69] S. Morimoto,et al. Tetrahydrocannabinolic acid synthase, the enzyme controlling marijuana psychoactivity, is secreted into the storage cavity of the glandular trichomes. , 2005, Plant & cell physiology.